Amanda Templeton
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Amanda Templeton has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Joel M. Guthridge
Oklahoma Medical Research Foundation
3 shared publications - Jennifer A. Kelly
Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA
2 shared publications John B. Harley
Division of Rheumatology, Cincinnati Children's Hospital, 3333 Burnet Avenue, Cincinnati, OH 45229, USA
2 shared publications- Patrick M. Gaffney
Genes and Human Disease Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA
2 shared publications Anne M Stevens
Division of Rheumatology, Department of Pediatrics, University of Washington, Seattle, Washington, USA
1 shared publicationBarry I Freedman
Department of Internal Medicine, Wake Forest University Health Sciences, Winston-Salem, North Carolina, USA
1 shared publication
Latest Publications
- Open Access
- 22 February 2012
- Published by Wiley in Journal of Biomedicine and Biotechnology
- Vol. 2012, 1-12
Effects of IRF5 Lupus Risk Haplotype on Pathways Predicted to Influence B Cell Functions
Both genetic and environmental interactions affect systemic lupus erythematosus (SLE) development and pathogenesis. One known genetic factor associated with lupus is a haplotype of the interferon regulatory factor 5 (IRF5) gene. Analysis of global gene expression microarray data using gene set enrichment analysis identified multiple interferon- and inflammation-related gene sets significantly overrepresented in cells with the risk haplotype. Pathway analysis using expressed genes from the significant gene sets impacted by theIRF5risk haplotype confirmed significant correlation with the interferon pathway, Toll-like receptor pathway, and the B-cell receptor pathway. SLE patients with theIRF5risk haplotype have a heightened interferon signature, even in an unstimulated state (), while patients with theIRF5protective haplotype have a B cell interferon signature similar to that of controls. These results identify multiple genes in functionally significant pathways which are affected by IRF5 genotype. They also establish the IRF5 risk haplotype as a key determinant of not only the interferon response, but also other B-cell pathways involved in SLE.- 22 February 2012
- Published by Wiley in Journal of Biomedicine and Biotechnology
- Vol. 2012, 1-12
Open AccessEffects of IRF5 Lupus Risk Haplotype on Pathways Predicted to Influence B Cell Functions
Both genetic and environmental interactions affect systemic lupus erythematosus (SLE) development and pathogenesis. One known genetic factor associated with lupus is a haplotype of the interferon regulatory factor 5 (IRF5) gene. Analysis of global gene expression microarray data using gene set enrichment analysis identified multiple interferon- and inflammation-related gene sets significantly overrepresented in cells with the risk haplotype. Pathway analysis using expressed genes from the significant gene sets impacted by theIRF5risk haplotype confirmed significant correlation with the interferon pathway, Toll-like receptor pathway, and the B-cell receptor pathway. SLE patients with theIRF5risk haplotype have a heightened interferon signature, even in an unstimulated state (), while patients with theIRF5protective haplotype have a B cell interferon signature similar to that of controls. These results identify multiple genes in functionally significant pathways which are affected by IRF5 genotype. They also establish the IRF5 risk haplotype as a key determinant of not only the interferon response, but also other B-cell pathways involved in SLE. - 20 February 2011
- Published by Springer Nature in Nature Genetics
- Vol. 43 (3) , 253-258
Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus
Patrick Gaffney and colleagues perform a fine-mapping study of the TNFAIP3 region in systemic lupus erythematosus using individuals from diverse ancestral populations. They identify a putative causal variant in a region of high conservation and regulatory potential that is associated with reduced TNFAIP3 expression. Systemic lupus erythematosus (SLE, MIM152700) is an autoimmune disease characterized by self-reactive antibodies resulting in systemic inflammation and organ failure. TNFAIP3, encoding the ubiquitin-modifying enzyme A20, is an established susceptibility locus for SLE. By fine mapping and genomic re-sequencing in ethnically diverse populations, we fully characterized the TNFAIP3 risk haplotype and identified a TT>A polymorphic dinucleotide (deletion T followed by a T to A transversion) associated with SLE in subjects of European (P = 1.58 × 10−8, odds ratio = 1.70) and Korean (P = 8.33 × 10−10, odds ratio = 2.54) ancestry. This variant, located in a region of high conservation and regulatory potential, bound a nuclear protein complex composed of NF-κB subunits with reduced avidity. Further, compared with the non-risk haplotype, the haplotype carrying this variant resulted in reduced TNFAIP3 mRNA and A20 protein expression. These results establish this TT>A variant as the most likely functional polymorphism responsible for the association between TNFAIP3 and SLE.
- 20 February 2011
- Published by Springer Nature in Nature Genetics
- Vol. 43 (3) , 253-258
Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus
Patrick Gaffney and colleagues perform a fine-mapping study of the TNFAIP3 region in systemic lupus erythematosus using individuals from diverse ancestral populations. They identify a putative causal variant in a region of high conservation and regulatory potential that is associated with reduced TNFAIP3 expression. Systemic lupus erythematosus (SLE, MIM152700) is an autoimmune disease characterized by self-reactive antibodies resulting in systemic inflammation and organ failure. TNFAIP3, encoding the ubiquitin-modifying enzyme A20, is an established susceptibility locus for SLE. By fine mapping and genomic re-sequencing in ethnically diverse populations, we fully characterized the TNFAIP3 risk haplotype and identified a TT>A polymorphic dinucleotide (deletion T followed by a T to A transversion) associated with SLE in subjects of European (P = 1.58 × 10−8, odds ratio = 1.70) and Korean (P = 8.33 × 10−10, odds ratio = 2.54) ancestry. This variant, located in a region of high conservation and regulatory potential, bound a nuclear protein complex composed of NF-κB subunits with reduced avidity. Further, compared with the non-risk haplotype, the haplotype carrying this variant resulted in reduced TNFAIP3 mRNA and A20 protein expression. These results establish this TT>A variant as the most likely functional polymorphism responsible for the association between TNFAIP3 and SLE.
- 1 February 2009
- Published by Elsevier in Autoimmunity Reviews
- Vol. 8 (4) , 337-342
Aberrant Epstein–Barr viral infection in systemic lupus erythematosus
- 1 February 2009
- Published by Elsevier in Autoimmunity Reviews
- Vol. 8 (4) , 337-342
Aberrant Epstein–Barr viral infection in systemic lupus erythematosus
- 1 June 2008
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 197 (1) , 37-46
Chemical sympathectomy increases susceptibility to ocular herpes simplex virus type 1 infection
- 1 June 2008
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 197 (1) , 37-46
Chemical sympathectomy increases susceptibility to ocular herpes simplex virus type 1 infection